Department of Thai Traditional Medicine
The Department of Thai Traditional Medicine refers to Thailand’s traditional-medicine public-health function involved in the medical framing of cannabis policy. In cannabis reports, it is relevant because Thailand’s legal pathway emphasized medical and traditional uses rather than a purely recreational market. Its role is regulatory and administrative: setting or supporting rules, programmes, compliance expectations, and acceptable use cases. Operators are affected by this framework through licensing, product positioning, medical documentation, cultivation standards, and the distinction between compliant medical activity and prohibited recreational sales.
Profile overview
The Department of Thai Traditional Medicine refers to Thailand’s traditional-medicine public-health function involved in the medical framing of cannabis policy. In cannabis reports, it is relevant because Thailand’s legal pathway emphasized medical and traditional uses rather than a purely recreational market. Its role is regulatory and administrative: setting or supporting rules, programmes, compliance expectations, and acceptable use cases. Operators are affected by this framework through licensing, product positioning, medical documentation, cultivation standards, and the distinction between compliant medical activity and prohibited recreational sales.
Regulatory program areas
Medical cannabis framework
Traditional medicine pathway licensing
The department administers the traditional-medicine lens of Thailand's cannabis policy, treating cannabis flower as a controlled herb under the Traditional Medicine Wisdom Protection and Promotion Act rather than under the Narcotics Code. This classification defines which practitioners, programmes, and dispensary formats can legally operate post-2025 recriminalisation.
Prescription gating
30-day prescription requirement
Under the June 2025 cannabis notification, patients must obtain a prescription valid for 30 days from a licensed traditional or modern medicine practitioner to access cannabis flower legally. The prescription regime is the primary commercial gating mechanism determining which dispensaries can operate and which patient populations can access product.
Traditional medicine integration
Cannabis in Thai herbal medicine
The department supports research and clinical development of cannabis as an ingredient in Thai traditional herbal preparations, including pain relief, appetite stimulation, and nausea management. GPO's medical-cannabis programme and licensed hospital dispensing sit within this traditional-medicine legitimacy frame.
Enforcement coordination
Distinction between herb and narcotic
Cannabis flower is classified as a controlled herb; extracts with THC exceeding 0.2% remain narcotics under the Narcotics Code. The department coordinates with MoPH enforcement agencies to maintain this classification distinction, which determines whether informal dispensaries face administrative or criminal penalties.
Thailand cannabis regulation timeline and status
Cannabis decriminalisation
Date
June 2022
Impact on operators
Flower removed from narcotics list; dispensary boom
Reclassification as controlled herb
Date
Late 2024
Impact on operators
Medical/traditional use only; prescription requirement emerging
June 2025 notification — 30-day prescription regime
Date
June 2025
Impact on operators
7,000+ dispensaries forced to close or convert to medical model
GPO medical-cannabis programme ongoing
Date
Ongoing
Impact on operators
State-produced medical-grade cannabis; benchmark for legitimate supply
Extracts (>0.2% THC) — narcotics classification maintained
Date
Ongoing
Impact on operators
Extracts remain prohibited without specific medical exemption
| Regulatory event | Date | Impact on operators |
|---|---|---|
| Cannabis decriminalisation | June 2022 | Flower removed from narcotics list; dispensary boom |
| Reclassification as controlled herb | Late 2024 | Medical/traditional use only; prescription requirement emerging |
| June 2025 notification — 30-day prescription regime | June 2025 | 7,000+ dispensaries forced to close or convert to medical model |
| GPO medical-cannabis programme ongoing | Ongoing | State-produced medical-grade cannabis; benchmark for legitimate supply |
| Extracts (>0.2% THC) — narcotics classification maintained | Ongoing | Extracts remain prohibited without specific medical exemption |
Watchpoints 2025-2026
Enforcement
Prescription-regime compliance
7,000-plus dispensaries closed or converted following the June 2025 notification. Enforcement consistency across Bangkok, tourist areas, and provincial markets will determine how many informal operators continue selling without prescriptions, undermining the medical-only framework.
GPO programme
State medical cannabis supply
Government Pharmaceutical Organisation (GPO) medical cannabis products are the benchmark for legitimate, regulated supply. If GPO production capacity is insufficient to meet licensed practitioner prescription demand, shortfalls could create informal substitution channels that blur the medical-only boundary.
Legal evolution
Cannabis Act drafting
A dedicated Cannabis Act to replace the current ministerial-notification approach was under discussion as of 2025. The Act's provisions on recreational use, tourist exemptions, and export rights will determine the long-term regulatory ceiling for the Thai cannabis industry.
Source-pack context
Department of Thai Traditional Medicine is linked to existing Insight report coverage through tracked source packs. The cited sources provide the current evidence trail for market context, regulatory exposure, operator positioning, or sector structure; exact numeric claims should still be checked against raw snapshots before being surfaced as headline metrics.[, , ]
Deep operating read
The Department of Thai Traditional Medicine is the medical / traditional-use policy layer in Thailand's cannabis reversal. The source pack frames the arc from June 2022 decriminalisation to 2024/2025 recriminalisation and medical-only gating, with cannabis flower reclassified as a controlled herb under the Thai Traditional Medicine Wisdom Protection and Promotion Act. Its operating relevance is rule-setting: prescriptions, practitioner channels, acceptable medical use cases and compliance expectations determine which dispensaries survive.[, , ]
Execution watchpoints
Watch enforcement of the 30-day prescription regime, licensed-practitioner gating and the distinction between controlled-herb flower and >0.2% THC extracts treated as narcotic. Nation Thailand quantifies the industry shock as 7,000+ dispensaries closing between the June 2025 notification and early 2026. The GPO medical-cannabis programme remains the state-production comparator for medical-only legitimacy.[, , , ]
Related Market profiles
Peers, parents, partners, agencies, and other Cannabis Regulation actors.